AGPTNA Chain A, Pcbp2 Kh1-Kh2 Domains (38-58)

AGPTNA Chain A, Pcbp2 Kh1-Kh2 Domains (38-58) is a synthetic peptide fragment derived from the poly(rC)-binding protein 2 (PCBP2), specifically encompassing the KH1 and KH2 domains within amino acid residues 38 to 58. As a structurally defined region of PCBP2, this peptide represents a critical segment involved in the nucleic acid-binding activities characteristic of KH (K homology) domains. The sequence is of particular interest to researchers investigating RNA-protein interactions, post-transcriptional gene regulation, and the modular architecture of RNA-binding proteins. Its precise delineation enables targeted studies into the mechanistic roles of KH domains in cellular RNA metabolism, making it a valuable tool for advancing understanding in molecular biology and biochemistry.

Protein-RNA Interaction Studies: The peptide is widely used as a model system for dissecting the molecular basis of KH domain-mediated RNA recognition. By providing a defined segment of the PCBP2 protein, it allows researchers to investigate sequence-specific and structural determinants of RNA binding. Such studies are essential for elucidating how KH domains recognize and interact with target RNA motifs, contributing to the broader field of post-transcriptional gene regulation.

Structural Biology: The defined sequence of the AGPTNA Chain A, Pcbp2 Kh1-Kh2 Domains (38-58) peptide is highly suitable for structural analyses using techniques such as nuclear magnetic resonance (NMR) spectroscopy or X-ray crystallography. Researchers utilize this fragment to resolve secondary and tertiary structures of the KH domains in isolation, facilitating detailed characterization of their folding patterns, conformational flexibility, and interaction surfaces. Insights gained from these studies inform the design of experiments probing protein-RNA complex formation and the dynamics of modular RNA-binding proteins.

Peptide-Protein Interaction Assays: The peptide serves as a specialized probe in biochemical assays aimed at mapping protein-protein interactions involving the KH1 and KH2 domains of PCBP2. By employing this fragment in pull-down, crosslinking, or competition assays, scientists can identify and characterize binding partners, elucidate interaction stoichiometry, and define the specificity of domain-mediated associations. This information is fundamental for understanding the role of PCBP2 in multi-protein complexes and its broader functional networks within the cell.

Antibody Generation and Validation: The AGPTNA Chain A, Pcbp2 Kh1-Kh2 Domains (38-58) peptide is employed as an immunogen or epitope standard in the development and validation of domain-specific antibodies. Such antibodies are instrumental in immunoprecipitation, western blotting, and immunofluorescence applications, enabling selective detection and quantification of PCBP2 or its KH domain-containing fragments in complex biological samples. The use of a well-defined peptide enhances the specificity and reproducibility of antibody-based assays.

Functional Domain Mapping: Researchers use the peptide to systematically map functional regions within PCBP2, particularly focusing on the roles of KH1 and KH2 domains in mediating nucleic acid interactions and regulatory activities. By integrating mutational analysis, binding assays, and functional reconstitution experiments, the peptide enables detailed dissection of domain contributions to the overall activity of PCBP2. Such studies provide a foundation for understanding domain modularity and its impact on the biological functions of RNA-binding proteins.

1. C-peptide and its C-terminal fragments improve erythrocyte deformability in type 1 diabetes patients

2. P-selectin and Complement’s Role in a Neonatal Model of Germinal Matrix Hemorrhage-Induced Secondary Injury

3. Multifunctional peptide-oligonucleotide conjugate promoted sensitive electrochemical biosensing of cardiac troponin I

4. GLP-1, exendin-4 and C-peptide regulate pancreatic islet microcirculation, insulin secretion and glucose tolerance in rats

5. Genetic, cellular, and structural characterization of the membrane potential-dependent cell-penetrating peptide translocation pore